Stay updated on Pembrolizumab+Cisplatin+IMRT in Head & Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+Cisplatin+IMRT in Head & Neck Cancer Clinical Trial page.

Latest updates to the Pembrolizumab+Cisplatin+IMRT in Head & Neck Cancer Clinical Trial page
- Check5 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check12 days agoChange DetectedThe website footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedA new revision entry v3.7.0 was added to the Study Record Versions. The previous entry v3.6.6 was removed from the list in the history.SummaryDifference0.1%

- Check54 days agoChange DetectedThe record history now shows a new revision v3.6.6 and removes the previous revision v3.6.5, indicating the study record has been updated to a newer version. This reflects version control activity rather than changes to the substantive study data.SummaryDifference0.1%

- Check76 days agoChange DetectedThe study history shows a new Revision: v3.6.5, replacing the prior v3.6.4. This indicates an update to the record's metadata rather than any change to the trial data.SummaryDifference0.1%

- Check90 days agoChange DetectedA new revision entry v3.6.4 was added to the study record history, and the previous revision v3.6.3 was removed from the visible history.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab+Cisplatin+IMRT in Head & Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Cisplatin+IMRT in Head & Neck Cancer Clinical Trial page.